Clinical Trials Logo

Thyroid Cancer, Medullary clinical trials

View clinical trials related to Thyroid Cancer, Medullary.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03647657 Completed - Clinical trials for Thyroid Cancer, Medullary

177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Start date: December 13, 2018
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to determine the use of 177Lu-PP-F11N for imaging and therapy of patients with advanced medullary thyroid carcinoma (MTC). 177Lu-PP-F11N is a gastrin analogon, binding to cholecystokinin-2 receptors. This receptors show an overexpression on more than 90 % of medullary thyroid carcinomas.